Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,756 across all filing types
Latest filing 2025-08-02 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Announcement under reg 30
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchanges (BSE and NSE) informing them about the completion of a USFDA inspection at a manufacturing facility with zero observations. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which typically covers material events or information that companies must disclose to the stock exchanges. The document does not contain financial data, audit results, or detailed reports but is a regulatory announcement about an event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-02 English
Transcript of conference call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing a transcript of a conference call with analysts and investors regarding the financial results for the quarter ended June 30, 2025. It states that the transcript has been placed on the company's website and requests the exchange to take note. The document itself does not contain the transcript but announces its availability. The length is only 1453 characters, which is short and consistent with an announcement rather than the full transcript. According to the rules, announcements of transcripts or reports that are short and refer to the report being available elsewhere should be classified as Regulatory Filings (RNS).
2025-07-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing a transcript of a conference call with analysts and investors regarding the financial results for the quarter ended June 30, 2025. It states that the transcript has been placed on the company's website and is not the transcript itself. The document length is short (1453 characters), and it serves as a notification of the transcript's availability rather than containing the transcript text. According to the classification rules, such a document is best classified as a Call Transcript (CT) since it relates to a conference call transcript, but since the transcript itself is not included and only a notification is provided, it fits the category of Regulatory Filings (RNS) as a notification. However, the document specifically mentions the transcript of the conference call, which is a Call Transcript. Given the document is a notification letter and not the transcript itself, the best fit is Regulatory Filings (RNS).
2025-07-31 English
Shareholders meeting
Regulatory Filings
2025-07-29 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchanges reporting the proceedings of the 52nd Annual General Meeting (AGM) held on 28th July 2025. It lists the business transacted at the AGM, including approval of financial statements, dividend declarations, director appointments, remuneration approvals, borrowing limits, and other corporate actions. The document does not contain the full financial statements or detailed financial analysis but rather summarizes the meeting's agenda and outcomes. It also mentions that the declaration of voting results will be disclosed separately. The document length is 3881 characters, which is relatively short and consistent with an announcement rather than a full report. Given these factors, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including proceedings and summaries of business transacted.
2025-07-29 English
Declaration of Voting result and scrutinizer report
Regulatory Filings
2025-07-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.